Rasonable, Ezra .

HRN: 24-25-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
AMPICILLIN 500MG (VIAL)
07/10/2025
07/17/2025
IV
500mg
Q6h
Acute Bacterial Infection
Checking Initial Appropriateness 
07/11/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/11/2025
07/18/2025
PO
4.5ml
TID
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: